ipique
rotterdam biologics b.v. - bevacizumab - wet macular degeneration - oftalmologiske - treatment of neovascular (wet) age-related macular degeneration (amd).
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiske - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
vabysmo
roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - oftalmologiske - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiske - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
atlantis od od-formulering
bayer a/s - mefenpyr-diethyl, mefenpyr, iodosulfuron-methyl-na, iodosulfuron, mesosulfuron-methyl, mesosulfuron - od-formulering - 30 g/l mefenpyr-diethyl ; (~ 25,5 g/l mefenpyr) ; 2 g/l iodosulfuron-methyl-na ; (~ 1,86 g/l iodosulfuron) ; 10 g/l mesosulfuron-methyl ; (~ 9,72 g/l mesosulfuron)
fenix suspensionskoncentrat
bayer a/s - acionifen - suspensionskoncentrat - 600 g/l aclonifen
hussar od od-formulering
bayer a/s - mefenpyr-diethyl, mefenpyr, iodosulfuron-methyl-na, iodosulfuron - od-formulering - 300 g/l mefenpyr-diethyl ; (~ 255 g/l mefenpyr) ; 100 g/l iodosulfuron-methyl-na ; (~ 93,2 g/l iodosulfuron)
hussar plus od od-formulering
bayer a/s - mefenpyr-diethyl, mefenpyr, iodosulfuron-methyl-na, iodosulfuron, mesosulfuron-methyl, mesosulfuron - od-formulering - 250 g/l mefenpyr-diethyl ; (~ 212 g/l mefenpyr) ; 50 g/l iodosulfuron-methyl-na ; (~ 46,6 g/l iodosulfuron) ; 7,5 g/l mesosulfuron-methyl ; (~ 7,29 g/l mesosulfuron)
aliette wg 80 vanddispergerbart granulat
bayer a/s - fosetyl-al, fosetyl - vanddispergerbart granulat - 800 g/kg fosetyl-al ; (~ 249 g/kg fosetyl)
previcur energy vandopløseligt koncentrat
bayer a/s - propamocarb, fosetyl-al, fosetyl - vandopløseligt koncentrat - 530 g/l propamocarb ; 310 g/l fosetyl-al ; (~ 96,3 g/l fosetyl)